David Milligan, M.D. Net Worth & Insider Trades

David Milligan, M.D. - Director, Madrigal Pharmaceuticals, Inc

As of June 21, 2022

What is David Milligan, M.D.'s Net Worth?

The current estimated net worth of Madrigal Pharmaceuticals, Inc's Director, David Milligan, M.D., is estimated to be about $6.38M . David Milligan, M.D. owns about 20,000 units of Madrigal Pharmaceuticals, Inc common stock. In the last 5 years at Madrigal Pharmaceuticals, Inc, David Milligan, M.D. has sold an estimated value of $3.57M worth.

What is David Milligan, M.D.'s Past Insider Trading?

David Milligan, M.D.'s largest sale order was 20,000 units , worth over $2.25M on February 26, 2020. In total, David Milligan, M.D. has made about 9 transactions over 5 years of their time at Madrigal Pharmaceuticals, Inc. David Milligan, M.D. usually trades in June, with the busiest year in 2018 and 2020. The most recent transaction was a sale order of 10,000 units , worth over $1.32M on February 26, 2020.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

David Milligan, M.D.

Date Range: All Time
Price per Share
Filing Date
No matching records found


Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is David Milligan, M.D.'s' Mailing Address?

  • Mailing address is 801 Interlaken Ln. Libertyville IL 60048 IL

Madrigal Pharmaceuticals, Inc Executive Compensation

Option Awards
Other Earnings Plans or Compensations
Other Compensation
Paul A. Friedman, M.D. 2020 $603,500 $3,468,500 $463,446 - - $4,535,446
Paul A. Friedman, M.D. 2019 $584,000 $5,122,000 $387,192 - - $6,093,192
Paul A. Friedman, M.D. 2018 $416,666 $4,907,500 $304,500 - - $5,628,666
Rebecca Taub, M.D. 2020 $490,833 $3,052,280 $339,230 - - $3,882,343
Rebecca Taub, M.D. 2019 $463,948 $4,531,120 $274,775 - - $5,269,843
Rebecca Taub, M.D. 2018 $385,416 $3,729,700 $225,330 - - $4,340,446
Remy Sukhija 2020 $337,500 $2,724,000 $274,680 $100,000 $2,722 $3,438,902
Marc R. Schneebaum 2020 $435,000 $2,219,840 $267,233 - $18,399 $2,940,472
Marc R. Schneebaum 2019 $421,000 $2,868,320 $223,298 - $20,034 $3,532,652
Marc R. Schneebaum 2018 $380,250 $2,748,200 $222,314 - $15,336 $3,366,100
Brian J. Lynch 2020 $425,417 $3,749,840 $260,946 - $11,690 $4,447,893
Brian J. Lynch 2019 $358,602 $3,506,859 $192,602 - $10,574 $4,068,637
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1157601/000119312521144922/d107927ddef14a.htm

What are Madrigal Pharmaceuticals, Inc's Past Insider Trades?

Madrigal Pharmaceuticals, Inc's most recent insider trade came on December 6, 2023 by Brian J. Lynch who sold 2,800 units worth $621.29K . In the last 6 years, insiders at Madrigal Pharmaceuticals, Inc have sold an estimated value of $472.07M and bought an estimated value of $80.52M worth of shares. Insider trading is most common in June, with the busiest year in 2023. The most active traders at the company are Fred Craves, Director,  Richard Levy, Director,  and David Milligan, M.D., Director .


Date Range: All Time
Insider Names
Price per Share
Filing Date
No matching records found